Loughborough, United Kingdom

Tim Birkinshaw

This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tim Birkinshaw. Retrieved from https://idiyas.com/inventor/tim-birkinshaw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tim Birkinshaw: Innovator in Pharmaceutical Chemistry

Introduction

Tim Birkinshaw is a notable inventor based in Loughborough, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on novel compounds.

Latest Patents

Birkinshaw holds a patent for "Phenylheteroalkylamine derivatives." This patent describes novel compounds of formula (I), wherein R, R, X, Y, V, W, and Z are defined in the specification. The patent also covers pharmaceutically acceptable salts, enantiomers, and racemates of these compounds. These compounds serve as inhibitors of nitric oxide synthase, making them particularly useful in the treatment or prophylaxis of inflammatory diseases and pain.

Career Highlights

Tim Birkinshaw is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work has contributed to advancements in therapeutic options for various medical conditions.

Collaborations

Birkinshaw has collaborated with notable colleagues, including David R Cheshire and Antonio Mete. Their combined expertise has furthered research and development in their field.

Conclusion

Tim Birkinshaw's innovative contributions to pharmaceutical chemistry, particularly through his patent on Phenylheteroalkylamine derivatives, highlight his role as a key inventor in the industry. His work continues to impact therapeutic advancements and improve patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…